药物受理最新动态：Bristol-Myers Squibb CompanyBMS-986165...

Group 1 - The core point of the article is that Bristol-Myers Squibb Company has had its application for BMS-986165 tablets accepted by the National Medical Products Administration, with the acceptance date being December 18, 2025 [1] Group 2 - The application number for BMS-986165 tablets is JXHB2500170, categorized as a chemical drug supplementary application [1] - The companies involved in the application include Bristol-Myers Squibb Company and Patheon Inc. [1] - The registration classification for the application is listed as "none" [1]